ID: ALA4464728

Max Phase: Preclinical

Molecular Formula: C35H50O15

Molecular Weight: 710.77

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=C[C@@](C)(O)CC/C=C(\C)C(=O)O[C@@]12C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]1[C@@]1(CO)O[C@H]1[C@H]2OC(=O)/C(C)=C/CC/C(C)=C/CO

Standard InChI:  InChI=1S/C35H50O15/c1-6-33(5,44)13-8-11-21(4)30(43)50-34-14-16-45-32(48-31-25(41)24(40)23(39)22(17-37)46-31)26(34)35(18-38)28(49-35)27(34)47-29(42)20(3)10-7-9-19(2)12-15-36/h6,10-12,14,16,22-28,31-32,36-41,44H,1,7-9,13,15,17-18H2,2-5H3/b19-12+,20-10+,21-11+/t22-,23-,24+,25-,26+,27-,28+,31+,32+,33-,34+,35-/m1/s1

Standard InChI Key:  BPUZHYVVIBNUJW-PHSSMKOJSA-N

Associated Targets(non-human)

Chorioallantoic membrane 375 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Danio rerio 3092 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 710.77Molecular Weight (Monoisotopic): 710.3150AlogP: -0.04#Rotatable Bonds: 16
Polar Surface Area: 234.43Molecular Species: NEUTRALHBA: 15HBD: 7
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.20CX Basic pKa: CX LogP: 0.56CX LogD: 0.56
Aromatic Rings: 0Heavy Atoms: 50QED Weighted: 0.05Np Likeness Score: 2.86

References

1. Beladjila KA, Berrehal D, Kabouche Z, Germanò MP, D'Angelo V, De Tommasi N, D'Andrea F, Braca A, De Leo M..  (2019)  Antiangiogenic Activity of Compounds Isolated from Anarrhinum pedatum.,  82  (3): [PMID:30835462] [10.1021/acs.jnatprod.8b00893]

Source